The high sensitivity and specificity of 68Ga -labeled prostate-specific membrane antigen-ligand positron-emission tomography ([68Ga]Ga-PSMA-11 PET) for prostate cancer lesions has led to an increasing use over the past years [1]. Here, FOLH1 is linked to prostate cancer.